APA (7th ed.) Citation

Weng, J. J., Wang, L. H., Zhu, H., Xu, W. R., Wei, Y. M., Wang, Z. Y., . . . Li, H. F. (2019). Efficacy of low-dose D 2 /D 3  partial agonist pramipexole on neuroleptic-induced extrapyramidal symptoms and symptoms of schizophrenia: A stage-1 open-label pilot study. Neuropsychiatric disease and treatment, 15, 2195-2203. https://doi.org/10.2147/NDT.S205933

Chicago Style (17th ed.) Citation

Weng, Jia Jun, Li Hua Wang, Hao Zhu, Wen Rong Xu, Yu Mei Wei, Zhi Yang Wang, Wen Juan Yu, and Hua Fang Li. "Efficacy of Low-dose D 2 /D 3  partial agonist Pramipexole on Neuroleptic-induced Extrapyramidal Symptoms and Symptoms of Schizophrenia: A Stage-1 Open-label Pilot Study." Neuropsychiatric Disease and Treatment 15 (2019): 2195-2203. https://doi.org/10.2147/NDT.S205933.

MLA (9th ed.) Citation

Weng, Jia Jun, et al. "Efficacy of Low-dose D 2 /D 3  partial agonist Pramipexole on Neuroleptic-induced Extrapyramidal Symptoms and Symptoms of Schizophrenia: A Stage-1 Open-label Pilot Study." Neuropsychiatric Disease and Treatment, vol. 15, 2019, pp. 2195-2203, https://doi.org/10.2147/NDT.S205933.